OUTCOMES AND SUCCESSES
COMMERCIALISATION :
I have submitted an invention disclosure at CDIP - USyd . Inventors : Yaser Hadi Gholami ( Primary inventor ), Hushan Yuan , Lee Josephson , Georges El - Fakhri , Richard Mashmyar , Moses Q Wilks , Marc Normandin and Z . Kuncic .
This included evaluation of therapeutic outcomes for patients , computational modelling , publication and provision of advice regarding radiation related matters .
WHERE I AM NOW :
We
have
invented
a
theranostic
I Vital Postdoctoral Fellow at the School of Physics at the University of Sydney . I am also leading the nanomedicine team at the Bill Walsh Lab at the Kolling am currently a Sydney Building . As an early career researcher , I have been working on developing a theranostic magnetic nano - platform for multi - modal imaging and radiation therapy . The Sydney Vital Fellowship has given me the opportunity to develop innovative and groundbreaking clinical theranostic solutions for cancer medicine . I have also been awarded the prestigious 2020 Physics Grand Challenge grant by the University of Sydney School of Physics for my project Postronium the key for cancer annihilation . This grant will support my research project with $ 250 , 000 over two years .
Nano - platform
non -
magnetic invasively
for
detecting , and treating lymph node metastases . The technique uses the FDA approved nanoparticle Feraheme ( FH ). This multifunctional radio - nanomedicine platform can be used to detect , diagnose and treat lymph node metastases arising from any primary cancer site : breast , colorectal , prostate , lung , liver etc . diagnosing
INDUSTRY COLLABORATION :
I IDE approval from the U . S . Food and Drug Administration OncoPac - 1 U . S and International Clinical Study for pancreatic cancer Localised Internal Radionuclide Therapy ( LIRT ) using the 32P OncoSil microparticle . have contributed to achieving
P A G E
4 1
Made with FlippingBook - professional solution for displaying marketing and sales documents online